: • Order by AstraZeneca to purchase five APAS® Independence instruments • Total contract value is between AU$3.4 million to $4.1 million • Installation of first five instruments expected within the next six months, potential for additional orders to follow • Rollout is indicative of how other large pharmaceutical companies might consider adoption of the APAS® technology • Commercial traction is building with multinational pharmaceutical customers
Ann: ASTRAZENECA SALE & SERVICE CONTRACT UP TO A$4.1M, page-3
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
3.2¢ |
Change
-0.001(3.03%) |
Mkt cap ! $57.05M | |||
| Open | High | Low | Value | Volume |
| 3.3¢ | 3.4¢ | 3.2¢ | $47.88K | 1.453M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 804305 | 3.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.4¢ | 290909 | 1 |
View Market Depth
| Last trade - 15.30pm 08/08/2025 (20 minute delay) ? |
| CC5 (ASX) Chart |